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Abstract
Canine copper toxicosis is an autosomal recessive disorder characterized by hepatic copper accumulation resulting in liver
fibrosis and eventually cirrhosis. We have identified COMMD1 as the gene underlying copper toxicosis in Bedlington terriers.
Although recent studies suggest that COMMD1 regulates hepatic copper export via an interaction with the Wilson disease
protein ATP7B, its importance in hepatic copper homeostasis is ill-defined. In this study, we aimed to assess the effect of
Commd1 deficiency on hepatic copper metabolism in mice. Liver-specific Commd1 knockout mice (Commd1
Dhep) were
generated and fed either a standard or a copper-enriched diet. Copper homeostasis and liver function were determined in
Commd1
Dhep mice by biochemical and histological analyses, and compared to wild-type littermates. Commd1
Dhep mice were
viable and did not develop an overt phenotype. At six weeks, the liver copper contents was increased up to a 3-fold upon
Commd1 deficiency, but declined with age to concentrations similar to those seen in controls. Interestingly, Commd1
Dhep
mice fed a copper-enriched diet progressively accumulated copper in the liver up to a 20-fold increase compared to
controls. These copper levels did not result in significant induction of the copper-responsive genes metallothionein I and II,
neither was there evidence of biochemical liver injury nor overt liver pathology. The biosynthesis of ceruloplasmin was
clearly augmented with age in Commd1
Dhep mice. Although COMMD1 expression is associated with changes in ATP7B
protein stability, no clear correlation between Atp7b levels and copper accumulation in Commd1
Dhep mice could be
detected. Despite the absence of hepatocellular toxicity in Commd1
Dhep mice, the changes in liver copper displayed several
parallels with copper toxicosis in Bedlington terriers. Thus, these results provide the first genetic evidence for COMMD1 to
play an essential role in hepatic copper homeostasis and present a valuable mouse model for further understanding of the
molecular mechanisms underlying hepatic copper homeostasis.
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Introduction
As a redox catalyst, the trace element copper is essential to the
well-being of all living organisms (reviewed by [1,2,3,4]), in excess
however, copper can be highly toxic due to its participation in the
formation of reactive oxygen species (ROS). It is therefore
important to maintain a strict balance between the essentiality
and the toxicity of copper, and this involves a range of mechanisms
mediating copper uptake, transport, storage and excretion. The
importance of a balanced copper homeostasis in preventing
toxicity is clearly illustrated by various inherited hepatic copper
storage disorders such as Wilson disease (WD; OMIM #277900),
Indian childhood cirrhosis (ICC; OMIM #215600), endemic
Tyrolean infantile cirrhosis (ETIC; OMIM #215600) and
idiopathic copper toxicosis (ICT; OMIM #215600). In WD,
mutations in the ATP7B gene lead to copper accumulation in
different tissues, particularly in liver and brain. The genetic defects
underlying ICC, ETIC and ICT remain elusive, but the clinical
manifestation of these non-Wilsonian copper storage disorders
depends in most cases on an excessive dietary intake of copper
[5,6,7].
Another well-documented copper overload disorder is copper
toxicosis (CT) in Bedlington terriers. CT is an autosomal recessive
disease linked to a homozygous genomic deletion, encompassing
exon 2, of the COMMD1 gene [8]. Affected dogs are characterized
by hepatic copper overload, due to an inefficient copper excretion
via the bile, resulting in liver fibrosis and eventually cirrhosis
[9,10]. In contrast to WD, Bedlington terriers affected with CT do
not display any signs of neurological defects and have normal
serum concentrations of the copper-bound ferroxidase ceruloplas-
min (Cp) [10]. Although COMMD1 has been suggested as a
candidate gene for the non-Wilsonian copper storage disorders
ICC, ETIC and ICT, no mutations in COMMD1 have been
identified in these patients so far [11,12].
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considered as the prototype of the COMMD protein family,
which is highly conserved between eukaryotes and in some
protozoa [13,14]. The ten COMMD family members (COMMD1
210) share a C-terminal COMM domain of 70–85 amino acids
that mediates protein-protein interactions and nuclear export of
COMMD proteins [15,16,17]. Except for COMMD1, the
functions of most of the COMMD proteins are largely unknown.
Several studies on COMMD1 have provided supportive evidence
of its role in copper homeostasis. First, COMMD1 interacts with
the copper transporter ATP7B, and is suggested to regulate its
proteolysis [18,19,20]. Second, down-regulation of COMMD1
expression results in increased intracellular copper concentrations
both in HEK293T cells and the mouse hepatoma Hepa1-6 cells
[20,21]. Third, we recently demonstrated that the copper
transporting activity of ATP7A, a copper transporter with high
homology to ATP7B, is also mediated by COMMD1 expression
[22]. Besides its role in copper homeostasis, COMMD1 is also
implicated in several other pathways, such as sodium transport,
antioxidant defense, and NF-kB and hypoxia signaling
[17,23,24,25,26,27,28,29,30]. Interestingly, in contrast to dogs
deficient for COMMD1, a genetic deletion of Commd1 in mice
results in embryonic lethality [31]. Altogether, these data illustrate
that COMMD1 is a protein with a pleiotropic function, although
its role in hepatic copper metabolism is still not well defined. To
gain more insight into the function of COMMD1 in hepatic
copper homeostasis in particular, and to circumvent the
embryonic lethality of the Commd1 knockout mice, we generated
a hepatocyte-specific Commd1 knockout mouse. Here, we provide
the first genetic evidence that Commd1 is essential for hepatic
copper excretion as Commd1-deficient mice show increased
intrahepatic copper levels when their dietary copper intake is
increased.
Results
Generation of a hepatocyte-specific Commd1 knockout
mouse model
To circumvent embryonic lethality in Commd1-deficient mice
and thus study the function of Commd1 in vivo, we generated a
conditional Commd1 knockout mouse. A Commd1 targeting
construct was designed to flank exon 1 of Commd1 with loxP
recombination sites by homologous recombination (Figure 1A).
After confirming homologous recombination by long–range PCR
(data not shown), the mice were further genotyped by multiplex
PCR as described in Materials and Methods and Figure 1B.
Germline deletion of Commd1 resulted in embryonic lethality
between days 9.5 and 10.5 of gestation (data not shown), similar to
what we have demonstrated previously [31].
To elucidate the role of COMMD1 in hepatic copper
metabolism, we deleted Commd1 specifically in hepatocytes using
the transgenic Albumin-Cre (Alb-Cre) mice (Figure S1), referred to
as Commd1
Dhep mice from here onwards. Commd1
Dhep mice were
born in the expected Mendelian frequency. The total body and
liver weights of the Commd1
Dhep mice were comparable to control
littermates (Commd1
loxP/loxP) (Table S1). Immunoblot analyses of
liver homogenates prepared from Commd1
Dhep mice showed an
almost complete loss of Commd1 expression relative to Comm-
d1
loxP/loxP mice (Figure 1C). As expected, a residual Commd1
expression was observed as the Alb-Cre transgene is selectively
expressed in the parenchymal cells, but not in the non-
parenchymal cells present in the liver (e.g. Kupffer, endothelial,
and stellate cells) [32]. Commd1 expression in other tissues of the
Commd1
Dhep mice was unaffected (data not shown).
Ablation of hepatic Commd1 results in elevated copper
concentrations in the livers of young mice
Since loss of COMMD1 in Bedlington terriers results in hepatic
copper accumulation, we investigated the consequence of hepatic
Commd1 deficiency on the amount of hepatic copper in the livers
of Commd1
Dhep mice of different ages (6, 9, 12, 34, 46 and 58
weeks; Table S1). At an age of six weeks, hepatic copper
concentrations were significantly increased in Commd1
Dhep mice
compared to control animals (Commd1
loxP/loxP) (46.269.9 vs.
13.762.0 mg/g dlw, respectively; Figure 2A and Table S1).
However, during adolescence, the amount of copper in the livers
of Commd1
Dhep mice declined to levels similar to those of the
control mice (Figure 2A and Table S1). Although hepatic
Commd1 ablation resulted in elevated hepatic copper pools,
analysis of the mRNA expression of the copper-responsive genes
metallothionein I and II (Mt-I and Mt-II) revealed no significant
changes between six week-old Commd1
Dhep and Commd1
loxP/loxP
mice (Figure 2B). Interestingly, the protein levels of Atp7b were
markedly reduced in the livers of Commd1
Dhep mice at this age
(Figure 2C, 2D), while the Atp7b mRNA expression remained
unaffected (Figure 2E). However, over time, Atp7b increased to
levels comparable to those seen in control mice (Figure 2F), and
correlated perfectly with the decline in hepatic copper concentra-
tions in Commd1
Dhep mice, starting at an age of nine weeks
(Figure 2A and Table S1). Further, no alterations in the serum Cp
activity or protein levels could be detected in six week-old
Commd1
Dhep compared to Commd1
loxP/loxP mice in spite of the
reduced Atp7b levels upon Commd1 deficiency (Table S1 and
data not shown). As no differences in serum Cp activity were seen
between the two groups at all studied ages (Table S1), our data
imply that incorporation of copper into Cp in the trans-Golgi
network is not affected by hepatic Commd1 ablation.
Despite the increased hepatic copper levels in six week-old
Commd1
Dhep mice, no overt macroscopic nor microscopic differ-
ences were identified between livers of Commd1
Dhep and Comm-
d1
loxP/loxP mice (data not shown). Furthermore, copper deposits
could not be visualized in Commd1
Dhep mice livers (data not shown).
Consistent with the absence of liver pathology, no differences in
the liver enzyme serum levels of glutamic oxaloacetic transaminase
(GOT) and glutamic pyruvic transaminase (GPT) were observed
(Table S1). Taken together, these data demonstrate that ablation
of hepatic Commd1 results in a temporary copper accumulation in
young mice without inducing any hepatocellular damage.
Progressive hepatic copper accumulation in Commd1
Dhep
mice fed a high copper diet
Since the occurrence of copper toxicosis is often dependent on
dietary copper intake [5,6,7,9], we challenged Commd1
Dhep and
control mice with a copper-enriched diet and followed them over
time. For this, CuCl2 was supplemented to the drinking water to a
final concentration of 6 mM (fed ad libitum). High dietary copper
had no effect on the total body and liver weights of either
Commd1
loxP/loxP or Commd1
Dhep mice (Table S2), but clearly
affected the hepatic copper concentrations (Figure 3A and Table
S2). After three weeks of high dietary copper intake, starting at an
age of six weeks, Commd1 deficiency resulted in markedly raised
hepatic copper relative to Commd1
loxP/loxP mice fed a standard diet
(195.8658.9 vs. 22.667.9 mg/g dlw, respectively). In contrast, the
hepatic copper concentrations of Commd1
loxP/loxP mice were
unaffected by the copper-enriched diet (25.8610.7 vs.
22.667.9 mg/g dlw). The highest copper concentrations were
measured in the livers of Commd1
Dhep mice fed the copper-enriched
diet for six weeks (338.3682.4 vs. 11.866.3 mg/g dlw), which
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decline in hepatic copper was observed in both genetic groups
(Figure 3A and Table S2).
Although a significant accumulation in hepatic copper was
observed in Commd1
Dhep mice fed a high copper diet, no
macroscopic or microscopic alterations in their liver pathologies
were identified (Figure S2 and data not shown). Neither were there
differences in the enzymatic activities of serum GOT and GPT
between the two groups (Table S2). Additionally, histological
hepatic copper deposits were undetectable in Commd1
Dhep mice
(data not shown). It was noteworthy that mRNA expression of Mt-
I and Mt-II was significantly increased in the livers of Commd1
Dhep
mice fed the copper-enriched diet for three weeks compared to
controls. However, no differences in Mt-I and Mt-II expression
were seen between the two genetic groups fed the copper-enriched
diet for six or more weeks (Figure 3B and data not shown).
Furthermore, we did not observe any differences in hepatic Atp7b
levels between Commd1
loxP/loxP and Commd1
Dhep mice (Figure 3C).
Yet, during aging, the serum Cp activity of Commd1
Dhep mice (28,
40 and 58 weeks old) was significantly increased relative to controls
(Figure 3D and Table S2).
Altogether, these results show that liver-specific Commd1-
deficient mice are susceptible to progressively accumulate hepatic
copper when overexposed to environmental copper. However,
hepatic deletion of Commd1 does not affect the incorporation of
copper into Cp.
Discussion
Although a genomic deletion of COMMD1 is associated with
CT in Bedlington terriers, the significance of COMMD1 in
mammalian copper homeostasis remains poorly defined. Here, we
examined the role of COMMD1 in hepatic copper homeostasis
using a liver-specific Commd1-deficient mouse model, and were
able to provide substantial evidence that Commd1 plays a role in
controlling copper homeostasis in hepatocytes. We demonstrated
that mice deficient for hepatic Commd1 are more susceptible to
hepatic copper accumulation compared to wild-type mice when
their dietary copper intake is increased. A significant increase in
hepatic copper concentrations was also observed in six week-old
Commd1
Dhep mice fed a standard diet, but these elevated levels
declined during adolescence to concentrations similar as seen in
Figure 1. Generation of hepatocyte-specific Commd1 knockout mouse. A.) Schematic representation of the Commd1 gene-targeting
strategy to generate a hepatic-specific Commd1 knockout mouse, including a map of the COMMD1 exon 1 allele and the targeting vector with loxP
sites (solid boxes), FRT sites (open boxes), and neomycin selection gene (Neo). Homologous recombination is marked with dotted lines. Hepatocyte-
specific deletion of Commd1 was accomplished by cross-breeding of Commd1
loxP/loxP mice with Alb-Cre mice. This resulted in the generation of
Commd1
Dhep mice (null allele). The locations of the PCR primer (P1, P2 and P3) binding sites used for genotyping are shown as open arrows.
(Expected fragments: WT: 500 bp, LoxP: 350 bp, Null: 300 bp) B.) PCR analysis of liver tissue DNA of Commd1 WT, WT/loxP, loxP/loxP and Null/WT
mice at six weeks of age. C is a negative control (H2O). C.) Immunoblot analysis of Commd1 expression in liver tissue of Commd1
loxP/loxP and
Commd1
Dhep mice. 30 mg tissue homogenates were analyzed by SDS-PAGE, and immunoblotted (IB) for Commd1 and a-Tubulin expression.
doi:10.1371/journal.pone.0029183.g001
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old Commd1
Dhep mice probably results from residual copper pools
accumulated in the preweaning period [33,34]. Dietary studies
have not been reported in Bedlington terriers with the homozy-
gous COMMD1 deletion, but since most commercial dog food
contains copper levels that exceed the minimum recommended
Figure 2. Ablation of hepatic Commd1 expression results in increased intracellular copper concentrations accompanied with
decreased Atp7b expression in young mice. A.) Hepatic copper concentrations were measured in dried liver tissue of Commd1
loxP/loxP (white
bars; n=6) and Commd1
Dhep mice (black bars; n=5) (6, 9 and 12 weeks of age) by means of FAAS. Data are represented as the hepatic copper
concentrations (mg/g dry liver weight) in all mice at indicated ages.
* indicates significantly different values compared to Commd1
loxP/loxP mice
(p,0.05). B.) Relative mRNA expression of metallothioneins Mt-I and Mt-II in liver tissue of Commd1
loxP/loxP (open dots; n=6) and Commd1
Dhep mice
(black dots; n=5) (six weeks of age) as determined by qPCR analysis. Expression was normalized for b-Actin mRNA levels, and relatively expressed to
Commd1
loxP/loxP mice. C.) Immunoblot analysis of liver tissue of Commd1
loxP/loxP and Commd1
Dhep mice at six weeks of age. 30 mg of liver
homogenates were analyzed by SDS-PAGE, and immunoblotted (IB) for expression of Atp7b and Commd1. Actin protein expression was used as the
loading control. D.) Densitometric quantification of Atp7b expression at six weeks of age (Figure 2C), normalized to Actin expression. Mean
expression of Commd1
loxP/loxP mice was set at 1 6 SD. p=0.0010. E.) Relative mRNA expression of Atp7b in liver tissue of Commd1
loxP/loxP (open dots;
n=5–6) and Commd1
Dhep mice (black dots; n=5–6) (6, 9 and 12 weeks of age) as determined by qPCR analysis. Expression was normalized for b-Actin
mRNA levels, and relatively expressed to Commd1
loxP/loxP mice. F.) Immunoblot analysis of Atp7b expression in liver tissue of Commd1
loxP/loxP and
Commd1
Dhep mice at 12 and 52 weeks of age.
doi:10.1371/journal.pone.0029183.g002
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reducing the gastrointestinal copper uptake by decreasing the
dietary copper content would be beneficial to the liver pathology
of affected dogs.
Although our mouse model partially recapitulates the copper
accumulation phenotype of Bedlington terriers affected with CT,
the exact mode of COMMD1 action in regulating hepatic copper
metabolism remains elusive. However, several assumptions can be
drawn from our data. Similar to Bedlington terriers, hepatic
Commd1 deficiency in mice does not affect the incorporation of
copper into Cp by Atp7b. Importantly, probably due to the
increased bioavailable hepatic copper, the biosynthesis of
holoceruloplasmin was even enhanced in middle-aged Commd1
Dhep
mice fed a copper-enriched diet compared to controls. Together
with the observation that the copper-induced trafficking of ATP7B
to the cell periphery is unaffected in COMMD1-deficient cells
[18,20], it is tempting to speculate that, in excess copper,
COMMD1 acts downstream of ATP7B and might be involved
in the final step of the secretory pathway to efficiently release
copper into the bile. This idea is further supported by the fact that
COMMD1 partly localizes to vesicles of the endocytic pathway
and cellular membranes, and shows only limited co-localization
with ATP7B in HepG2 cells [18,20]. However, COMMD1 is also
implicated in regulating the protein levels of ATP7B [18,20].
Whereas we previously demonstrated that COMMD1 expression
augments the protein degradation of ATP7B in vitro [18], others
have shown a decline in Atp7b expression after depletion of
Commd1 in the mouse hepatoma Hepa1-6 cells [20]. In line with
this latter observation, a marked decrease in hepatic Atp7b in six
week-old Commd1
Dhep mice was observed, and may account for the
increased hepatic copper levels observed in these animals.
However, no correlation was seen between the degree of copper
accumulation and Atp7b levels in Commd1
Dhep mice fed a copper-
enriched diet, which argues against the role of impaired Atp7b
protein stability in progressive copper accumulation in Commd1-
deficient hepatocytes. Additionally, no discrepancies in Atp7b
stability in primary Commd1-deficient hepatocytes compared to
WT control cells were seen (data not shown). Altogether, our data
indicate that COMMD1 controls hepatic copper homeostasis
downstream of ATP7B and may participate in the release of
copper into the bile. Further studies are however needed to
complete our understanding on the molecular function of
COMMD1 in hepatic copper homeostasis.
Interestingly, although Commd1
Dhep mice fed a copper-enriched
diet displayed a progressive increase in hepatic copper, no obvious
liver pathology using histological analysis were seen, even after
chronic exposure to high dietary copper. These data, supported by
biochemical parameters and together with the observation that the
mRNA expression of the copper-responsive genes Mt-I and Mt-II
was only increased in mice fed a copper-enriched diet for three
weeks, suggest that the accumulating copper upon Commd1
deletion is stored safely and does not reach a threshold
concentration sufficient to induce hepatocellular toxicity as seen
in CT-affected Bedlington terriers and mouse models for WD
[9,10,36]. Potentially, under these studied conditions, the levels of
Mt-I and Mt-II are sufficient to chelate the elevated copper.
Therefore, it would be of interest to complementary deplete Mt-I
and Mt-II [37] in our hepatic-specific Commd1 knockout mice and
assess the protective role of Mt-I and Mt-II in copper toxicity in
the absence of Commd1. In contrast to Commd1
Dhep mice fed a
high copper diet, which display copper concentrations of
approximately 340 mg/g of dlw, CT-affected dogs with moderate
to severe liver pathology show significantly more hepatic copper,
often in excess of 1,000 mg/g of dlw. The reason for the
interspecies differences is currently unknown and further studies
are required. Of particular interest in this would be defining the
degree of redundancy between the members of the Commd
protein family in murine copper homeostasis, as in addition to
COMMD1, COMMD2, 8 and 10 have also the ability to interact
with ATP7B (Figure S3A). Importantly, these interactions are
independent of COMMD1 expression (Figure S3B).
Together, our data conclusively shows that COMMD1 plays a
significant role in copper homeostasis and demonstrates that
hepatic copper accumulation due to loss of Commd1 is dependent
on excessive dietary copper intake. Given that elevated asymp-
tomatic hepatic copper in Atp7b deficient mice has a significant
effect on different metabolic pathways, such as lipid metabolism
[38,39,40], it would be of interest to investigate whether diet-
induced copper accumulation in Commd1
Dhep mice also affects
these pathways. We believe that our Commd1
Dhep mice represent a
valuable and interesting model for further elucidating the
molecular mechanism controlling hepatic copper homeostasis
and to understand the role of excess copper in various metabolic
pathways.
Materials and Methods
Generation and housing of transgenic mice
Detailed information regarding the generation of the hepato-
cyte-specific Commd1 knockout mice is available in Data S1 and
Figure S1. Mice were genotyped by a standard PCR method using
the primers as described in Table S3, and fed ad libitum with a
standard rodent diet containing 16.44 mg copper per kg (Special
Diet Services Ltd., UK). Animals of both sexes were included in
this study, and age-matched siblings were used as controls in all
experiments. All animal protocols (ID 2007.III.09.123) were
approved by the Institutional Animal Care and Use Committee
of Utrecht University (Utrecht, the Netherlands).
Copper treatment of mice
Starting from the age of six weeks, a subset of mice (consisting of
genotypes Commd1
loxP/loxP and Commd1
Dhep; n=5–8) were given
water supplemented with 6 mM CuCl2. As described previously,
these mice ingested approximately 50–100 times more copper
than mice fed a standard rodent diet [41].
Figure 3. Progressive copper accumulation in livers of Commd1
Dhep mice after copper challenging. A.) Hepatic copper concentrations
were measured in dried liver tissue of Commd1
loxP/loxP (white bars; n=4–6) and Commd1
Dhep mice (black bars, n=5–7) (fed a copper-enriched diet for
3, 6, 28, 40 and 52 weeks) by means of FAAS. Data are represented as hepatic copper concentrations (mg/g dry liver weight).
*,
** and
*** indicate
significantly different values compared to Commd1
loxP/loxP mice (
* p,0.05,
** p,0.005,
*** p,0.0005). B.) Relative mRNA expression of
metallothioneins Mt-I and Mt-II in liver tissue of Commd1
loxP/loxP (open dots; n=5–6) and Commd1
Dhep mice (black dots; n=5–7) (three and six weeks
fed a copper-enriched diet) as determined by qPCR analysis. Expression was normalized for b-Actin mRNA levels, and relatively expressed to
Commd1
loxP/loxP mice. C.) Immunoblot analysis of Atp7b and Commd1 in liver tissue of Commd1
loxP/loxP and Commd1
Dhep mice fed a copper-enriched
diet for 6 and 52 weeks. D.) Ceruloplasmin activity was determined in sera of Commd1
loxP/loxP (white bars; n=4–6) and Commd1
Dhep mice (black bars;
n=5–7) fed a copper-enriched diet for 3, 6, 28, 40 and 52 weeks. Data are represented as serum holoceruloplasmin activity (U/ml).
* and
** indicate
significantly different values compared to Commd1
loxP/loxP mice (
* p,0.05,
** p,0.01).
doi:10.1371/journal.pone.0029183.g003
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Mice were sacrificed and tissues were rapidly isolated, frozen in
liquid nitrogen, and stored at 280uC until use. Dissected tissues
were homogenized in ice-cold lysis buffer (25 mM kPi buffer;
pH 7.4, 0.5 M EDTA), supplemented with 100 mM PMSF and
protease inhibitors (Complete; Roche, Basal, Switzerland)). After
centrifugation, supernatants were used for further procedures.
Protein concentrations were determined by the Bradford Protein
Assay (Bio-Rad Laboratories Inc., Hercules, CA, USA).
Western blot analyses were performed using the following
antibodies: rabbit-anti-COMMD1 antiserum [42], polyclonal
rabbit-anti-Atp7b antiserum (kindly provided by Dr. J. Gitlin, St.
Louis, MO, USA), polyclonal rabbit-anti-Actin (Sigma-Aldrich, St.
Louis, MO, USA), and rabbit-anti-a-Tubulin (Abcam, Cam-
bridge, UK). In all analyses, equal amounts of proteins were
loaded on SDS-PAGE gels prior to transfer on to nitrocellulose
membranes.
RNA isolation and quantitative - RT-PCR
Total RNA was isolated from mouse liver by means of
TRIZOLH (Invitrogen Life Technologies Corporation, Carlsbad,
CA, USA). cDNA synthesis was performed using random
hexamers and SuperScript II reverse transcriptase (Invitrogen).
mRNA expression of Mt-I, Mt-II and Atp7b (primers previously
described by Huster et al. [36]) was analyzed by quantitative PCR
using iTaq
TM SYBRHGreen Supermix with ROX (Bio-Rad) and
7900 HT Fast Real-Time PCR System (Applied Biosystems,
Carlsbad, CA, USA). Results were presented as relative mRNA
expression, normalized to the expression of b-Actin (primer
sequences available on request).
Determination of hepatic copper concentrations
Liver tissues were dried at approximately 100uC until their
weights were stabilized. Dried tissues were digested for 1 h in
HNO3:H2O2 (ratio 3:1) at 95–100uC. After digestion, volumes
were equalized and copper concentrations were determined by
means of flame atomic absorption spectrometry (FAAS; Analytik
Jena ContrAAH 700, Analytik Jena AG, Jena, Germany). Hepatic
copper concentrations were corrected for dry liver weight (dlw)
and protein concentration.
Enzyme activity assays
Activity of the glutamic oxaloacetic transaminase (GOT) and
glutamic pyruvic transaminase (GPT) were quantified in serum
according to the manufacturer’s protocol (Spinreact, Sant Esteve
De Bas, Spain). Serum Cp activity was measured as described
previously [43].
Statistical analysis
The quantitative data in this paper is represented as means 6
SEM, unless stated otherwise. Statistical evaluation was made
using the Student’s t-test and differences were considered to be
significant at p,0.05.
Additional Materials and Methods can be found in the Data S1.
Supporting Information
Figure S1 Generation of hepatocyte-specific Commd1
knockout mouse. Schematic representation of the Commd1
gene-targeting strategy used to generate a hepatic specific Commd1
knockout mouse, including a map of the COMMD1 exon1 allele,
the targeting vector with loxP sites (solid boxes), FRT sites (open
boxes), and neomycin selection gene (Neo). Different restriction
sites are indicated and homologous recombination is marked with
dotted lines. The neomycin selection cassette was deleted by
crossbreed with the FLPe deleter mice, which target the FRT
sequences flanking neomycin. Subsequently, hepatocytespecific
deletion of Commd1 was accomplished by crossbreed of Comm-
d1
loxP/loxP mice with Alb-Cre mice. This resulted in the generation
of Commd1
Dhep mice (null allele). The locations of the PCR primer
(P1, P2 and P3) binding sites used for genotyping are shown as
open arrows.
(TIF)
Figure S2 Commd1
Dhep mice do not display any patho-
logical abnormalities relative to Commd1
loxP/loxP mice.
Liver sections (4 mm) of Commd1
loxP/loxP and Commd1
Dhep mice fed
a copper-enriched diet for 6 weeks were stained with H&E, and
analyzed by light microscopy (magnification 106).
(TIF)
Figure S3 COMMD2, COMMD8 and COMMD10 inter-
act with ATP7B, independently of COMMD1. A.)
Gluthatione-sepharose (GSH) precipitation of HEK293T cell
lysates transfected with cDNA constructs encoding GST or
each of the COMMD proteins fused to GST in combination
with ATP7B-Flag. Precipitates were washed and separated by
SDS-PAGE and immunoblotted as indicated. Input indicates
direct analyses of cell lysates. B.) HEK293T cells expressing a
stable knockdown of COMMD1 (shCOMMD1) were trans-
fected with cDNA constructs encoding an empty vector (pEBB)
or ATP7B-Flag in combination with either COMMD2,
COMMD8, or COMMD10 as GST fusion proteins as
indicated. HEK293T cells stably transfected with an empty
shRNA vector was used as a negative control (shControl). GSH
precipitation and immunoblot analysis was performed as
described under S3A. Equal loading was confirmed by
immunoblotting for SCHAD.
(TIF)
Table S1 Biological parameters of Commd1
loxP/loxP and
Commd1
Dhep mice fed a standard diet.
(PDF)
Table S2 Biological parameters of Commd1
loxP/loxP and
Commd1
Dhep mice fed a high Cu diet, starting at an age
of 6 weeks.
(PDF)
Table S3 Oligonucleotide sequences used for genotyp-
ing mice.
(DOC)
Data S1 Supplementary Materials and Methods.
(DOC)
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